-
CStone Announces Completion of $200 million Share Sale to Pfizer
prnasia
October 16, 2020
CStone Pharmaceuticals announced today the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. subscribed for newly issued CStone shares at approximately US$200 million (equivalent to approximately HK$1.55 billion)...
-
Roche Becomes Founding Partner in BaseLaunch
contractpharma
May 18, 2020
Basel Area-based incubator that helps entrepreneurs launch biotech companies begins next phase of its company building activities.
-
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US
PR Newswire
January 09, 2020
Patrick Lu, PhD, President and Chief Executive Officer of Sirnaomics, stated, "This collaborative effort between Sirnaomics and Innovent will be the first example of a combination strategy using an RNAi drug candidate together with an approved immune chec
-
Sumitomo Dainippon inks strategic collaboration with Roivant Sciences
biospectrumasia
September 06, 2019
To create broad strategic alliance to deliver promising new medicines to patients
-
Oxforb BioTherapeutics expands its strategic collaboration with WuXi Biologics
pharmafocusasia
December 12, 2018
WuXi Biologics (2269.HK), a leading global open source biological technology platform company offering integrated solutions for discovery, development and biological ....
-
Neovii, Mundipharma enter strategic collaboration
biospectrumasia
July 09, 2018
Grafalon is the recognised standard of care in leading transplant centres.
-
AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease
americanpharmaceuticalreview
March 20, 2017
AstraZeneca has entered a strategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation of Tudorza and Duaklir* in the US.